| Date Filed | Type | Description |
| 05/26/2023 |
4
| Valantine Hannah (Director) has filed a Form 4 on PACIFIC BIOSCIENCES OF CALIFORNIA, INC.|
Txns:
| Granted 25,775 options to buy
@ $11.94, valued at
$307.8k
|
|
| 01/09/2023 |
4
| Valantine Hannah (Director) has filed a Form 4 on CareDx, Inc.|
Txns:
| Granted 676 shares
@ $0 |
|
| 10/04/2022 |
4
| Valantine Hannah (Director) has filed a Form 4 on CareDx, Inc.|
Txns:
| Granted 422 shares
@ $0 |
|
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2022 |
4
| Valantine Hannah (Director) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Bought 1,764 shares
@ $14.23, valued at
$25.1k
|
|
| 10/26/2021 |
4
| Valantine Hannah (Director) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Granted 50,968 options to buy
@ $48.45, valued at
$2.5M
|
|
| 10/26/2021 |
3
| Valantine Hannah (Director) has filed a Form 3 on BridgeBio Pharma, Inc. |
| 10/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |